Significant reduction of the bias among commercial immunoassays for lipoprotein(a) after use of a uniform calibrator

Clinica Chimica Acta

Volumn 256, Issue 2, 1996, Pages 125-134

  Lippi, Giuseppe ^a   Lo Cascio, Claudia ^a   Ruzzenente, Orazio ^a   Brentegani, Claudio ^a   Guidi, Giancesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Atherosclerosis; Immunoassay; Lipoprotein(a); Purification

Indexed keywords

LIPOPROTEIN A;

ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; NEPHELOMETRY; NORMAL HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; STANDARDIZATION; TECHNIQUE;

BIAS (EPIDEMIOLOGY); CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; LIPOPROTEIN(A); NEPHELOMETRY AND TURBIDIMETRY; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0030607711     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06413-3     Document Type: Article

References (24)

1. [1] Rhoads GG, Dahlen GH, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986;256:2540-2544.
2. [2] Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990;36/ 1:20-23.
3. [3] Labeur C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vandekerckhove Y et al. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography. Clin Chem 1992;38:2261-2266.
4. [4] Jürgens G, Taddei-Peters W, Költringer P, Petek W, Chen Q, Greilberger J, Macomber P, Butman B, Stead A, Ransom J. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke 1995;26:1841-1848.
5. [5] Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Lipoprotein(a) and asymptomatic carotid artery disease. Stroke 1995;26:1582-1587.
6. [6] Cambillau M, Simon A, Amar J, Giral PH, Atger V, Segond P, Levenson J, Merli I, Megnien JL, Plainfosse MC, Moatti N and PCVMETRA Group. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. Arterioscler Thromb 1992;11:1346-1352.
7. [7] Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 1963;59:369-382.
8. [8] Albers JJ, Kennedy H, Mareovina SM. Evidence that Lp(a) contains one molecule of apo(a) and one molecule of apoB: evaluation of amino acid analysis data. J Lipid Res 1996;37:192-196.
9. [9] Marcovina S, Levine DM, Lippi G. Lipoprotein(a): structure, measurement and clinical significance. In: Rifai N, Warnick R, eds. Laboratory measurement of lipids, lipoproteins and apolipoproteins. AACC Press 1994:235-263.
10. [10] Albers JJ, Marcovina SM, Lodge MS. The unique lipoprotein(a): properties and immunochemical measurement. Clin Chim Acta 1990;36:2019-2026.
11. [11] Kostner GM. Standardization of Lp(a) assays. Clin Chem 1992;211:191-195.
12. [12] Guidi GC, Lippi G. Standardization of lipoprotein(a) measurements: an overview. Biochim Clin 1995;19:703-709.
13. [13] Lackner C, Cohen J, Hobbs H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Molec Genet 1993;2:933-940.
14. [14] Marcovina S, Zhang Z, Gaur V, Albers J. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993;191:1192-1196.
15. [15] Marcovina SM, Albers JJ, Gabel B, Koschinsky L, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 1995;41:246-255.
16. [16] Lippi G, Lo Cascio C, Ruzzenente O, Poli G, Brentegani C, Guidi GC. Simple and rapid procedure for the purification of lipoprotein(a). J Chromatogr B (in press).
17. [17] Lippi G, Ruzzenente O, Facchinetti R, Poli G, Schiesari F, Guidi GC. Latex immunonephelometry for lipopoprotein(a) assay. Eur J Lab Med 1994;2:23-28.
18. [18] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265-275.
19. [19] Marcovina SM, Albers JJ, Jacobs DR, Perkins LL, Lewis CE, Howard BV, Savage P. Lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in Caucasians and African Americans. Arterioscler Thromb 1993;13:1037-1045.
20. [20] Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample size. Part II. J Clin Chem Clin Biochem 1984;22:431-435.
21. [21] März W, Siekmeier R, Groß, E, Gr Groß, W. Determination of lipoprotein(a): enzyme immunoassay and immunoradiometric assay compared. Clin Chim Acta 1993;214:153-163.
22. [22] März W, Siekmeier R, Groß E, Kostner GM. Determination of lipoprotein(a): evaluation of three methods. Eur J Clin Chem Clin Biochem 1993;31:295-301.
23. [23] Leus F, Leerink C, Prins J and van Rijn H. Influence of apolipoprotein(a) phenotype on lipoprotein(a) quantification: evaluation of three methods. Clin Biochem 1994;27:449-455.
24. [24] Sundvall J, Sulonen GB, Hiltunen O, Kiuru J, Pursiainen M, Jauhiainen M. Comparison of a new immunoturbidimetric assay of human serum lipoprotein(a) to the ELISA and the IRMA methods. Scan J Clin Lab Invest 1995;55:171-180.